PH12014501654A1 - A drug delivery system - Google Patents

A drug delivery system

Info

Publication number
PH12014501654A1
PH12014501654A1 PH12014501654A PH12014501654A PH12014501654A1 PH 12014501654 A1 PH12014501654 A1 PH 12014501654A1 PH 12014501654 A PH12014501654 A PH 12014501654A PH 12014501654 A PH12014501654 A PH 12014501654A PH 12014501654 A1 PH12014501654 A1 PH 12014501654A1
Authority
PH
Philippines
Prior art keywords
delivery system
core
drug delivery
membrane
therapeutically active
Prior art date
Application number
PH12014501654A
Other languages
English (en)
Other versions
PH12014501654B1 (en
Inventor
Heikki Lyytikinen
Jukarainen Harri
Original Assignee
Bayer Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47666152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PH12014501654(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Oy filed Critical Bayer Oy
Publication of PH12014501654B1 publication Critical patent/PH12014501654B1/en
Publication of PH12014501654A1 publication Critical patent/PH12014501654A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • External Artificial Organs (AREA)
PH12014501654A 2012-01-23 2014-07-18 A drug delivery system PH12014501654A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20125069 2012-01-23
PCT/FI2013/050068 WO2013110856A1 (en) 2012-01-23 2013-01-22 A drug delivery system

Publications (2)

Publication Number Publication Date
PH12014501654B1 PH12014501654B1 (en) 2014-10-13
PH12014501654A1 true PH12014501654A1 (en) 2014-10-13

Family

ID=47666152

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12014501654A PH12014501654A1 (en) 2012-01-23 2014-07-18 A drug delivery system

Country Status (38)

Country Link
US (1) US10500381B2 (https=)
EP (1) EP2806893B1 (https=)
JP (1) JP6236401B2 (https=)
KR (1) KR102004014B1 (https=)
CN (1) CN104144702B (https=)
AR (1) AR089765A1 (https=)
AU (1) AU2013213514B2 (https=)
BR (1) BR112014017834B1 (https=)
CA (1) CA2861947A1 (https=)
CL (1) CL2014001935A1 (https=)
CO (1) CO7020911A2 (https=)
CR (1) CR20140358A (https=)
CU (1) CU24431B1 (https=)
CY (1) CY1120773T1 (https=)
DK (1) DK2806893T3 (https=)
DO (1) DOP2014000171A (https=)
EA (1) EA032208B1 (https=)
EC (1) ECSP14010605A (https=)
ES (1) ES2691635T3 (https=)
HR (1) HRP20181707T1 (https=)
IL (1) IL233599B (https=)
LT (1) LT2806893T (https=)
MX (1) MX355961B (https=)
MY (1) MY172812A (https=)
NZ (1) NZ627461A (https=)
PE (1) PE20141818A1 (https=)
PH (1) PH12014501654A1 (https=)
PL (1) PL2806893T3 (https=)
PT (1) PT2806893T (https=)
RS (1) RS57911B1 (https=)
SG (1) SG11201404032SA (https=)
SI (1) SI2806893T1 (https=)
TR (1) TR201815247T4 (https=)
TW (1) TWI626951B (https=)
UA (1) UA116197C2 (https=)
UY (1) UY34583A (https=)
WO (1) WO2013110856A1 (https=)
ZA (1) ZA201406206B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113842362A (zh) 2012-11-14 2021-12-28 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
US9820994B2 (en) * 2014-06-28 2017-11-21 Laboratorios Andromaco S.A. Cerclage pessary containing progesterone of prolonged, sustained, and continuous release useful for prevention of preterm birth
JP2019504021A (ja) * 2015-12-21 2019-02-14 バイエル・オーイュー 膣リングを製造する方法
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
MX2020007323A (es) * 2017-09-27 2020-09-07 Bayer Oy Un metodo para modificar la liberacion de un agente terapeuticamente activo de una matriz elastomerica.
CN109954198B (zh) * 2017-12-25 2021-10-12 先健科技(深圳)有限公司 药物球囊及其制备方法
CN113677326A (zh) * 2019-02-19 2021-11-19 粒子科学公司 隔室化药物递送装置

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0303306B1 (en) * 1987-08-08 1993-03-10 Akzo N.V. Contraceptive implant
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
US5916595A (en) * 1997-12-12 1999-06-29 Andrx Pharmaceutials, Inc. HMG co-reductase inhibitor
NZ330726A (en) * 1998-06-18 2000-10-27 Dec Res Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
WO2001085132A1 (en) 2000-05-10 2001-11-15 Leiras Oy Drug delivery device, especially for the delivery of levonorgestrel
WO2002032433A1 (en) * 2000-10-20 2002-04-25 Leiras Oy Drug delivery system
AU2002313517B2 (en) * 2001-08-31 2007-09-06 Bayer Schering Pharma Oy Drug delivery system
DE10209979A1 (de) 2002-03-07 2003-09-25 Ratiopharm Gmbh Arzneimittel mit Cholesterolspiegel-senkenden Wirkstoffen mit zeitverzögerter Wirkstofffreisetzung
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
US7279457B2 (en) 2004-03-12 2007-10-09 Biodel, Inc. Rapid acting drug delivery compositions
DK1629844T4 (da) 2004-07-13 2012-05-29 Bayer Schering Pharma Oy Retarderet indgivelsessystem med kontrolleret initialudbrud
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
EP1833469A2 (en) 2005-01-03 2007-09-19 Lupin Ltd. Pharmaceutical composition of acid labile substances
US9198871B2 (en) * 2005-08-15 2015-12-01 Abbott Products Gmbh Delayed release pancreatin compositions
US20060165776A1 (en) * 2005-08-31 2006-07-27 Ramesh Sesha Antidepressant oral pharmaceutical compositions
US8137327B2 (en) 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
NZ577014A (en) 2006-11-20 2011-07-29 Organon Nv Helically-shaped drug delivery system
TW200930343A (en) * 2007-09-21 2009-07-16 Organon Nv Drug delivery system
TW200927141A (en) 2007-11-22 2009-07-01 Bayer Schering Pharma Oy Vaginal delivery system
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI121000B (fi) 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
EP2658524A1 (en) * 2010-12-27 2013-11-06 Dow Corning Corporation Drug delivery dispersion and film formed therefrom

Also Published As

Publication number Publication date
ZA201406206B (en) 2019-06-26
RS57911B1 (sr) 2019-01-31
CU24431B1 (es) 2019-07-04
HK1203802A1 (en) 2015-11-06
PH12014501654B1 (en) 2014-10-13
PL2806893T3 (pl) 2019-01-31
LT2806893T (lt) 2018-12-10
AR089765A1 (es) 2014-09-17
EA032208B1 (ru) 2019-04-30
CY1120773T1 (el) 2019-12-11
NZ627461A (en) 2016-07-29
TW201343204A (zh) 2013-11-01
TWI626951B (zh) 2018-06-21
KR20140127262A (ko) 2014-11-03
PE20141818A1 (es) 2014-12-18
WO2013110856A1 (en) 2013-08-01
DK2806893T3 (en) 2018-11-05
US10500381B2 (en) 2019-12-10
US20140350488A1 (en) 2014-11-27
BR112014017834B1 (pt) 2021-05-18
CU20140094A7 (es) 2014-11-27
PT2806893T (pt) 2018-11-09
BR112014017834A2 (https=) 2017-06-20
IL233599B (en) 2019-07-31
CO7020911A2 (es) 2014-08-11
MX2014008906A (es) 2014-08-26
ECSP14010605A (es) 2015-12-31
CA2861947A1 (en) 2013-08-01
CR20140358A (es) 2014-11-17
JP2015504083A (ja) 2015-02-05
UY34583A (es) 2013-09-02
MX355961B (es) 2018-05-07
MY172812A (en) 2019-12-12
SI2806893T1 (sl) 2019-02-28
HRP20181707T1 (hr) 2019-02-22
AU2013213514A1 (en) 2014-08-07
CN104144702B (zh) 2018-03-06
JP6236401B2 (ja) 2017-11-22
ES2691635T3 (es) 2018-11-28
EP2806893A1 (en) 2014-12-03
AU2013213514B2 (en) 2017-07-13
UA116197C2 (uk) 2018-02-26
BR112014017834A8 (pt) 2017-07-11
SG11201404032SA (en) 2014-08-28
IL233599A0 (en) 2014-08-31
DOP2014000171A (es) 2014-08-15
CL2014001935A1 (es) 2015-04-10
EA201400834A1 (ru) 2014-12-30
TR201815247T4 (tr) 2018-11-21
CN104144702A (zh) 2014-11-12
EP2806893B1 (en) 2018-07-18
KR102004014B1 (ko) 2019-07-25

Similar Documents

Publication Publication Date Title
PH12014501654A1 (en) A drug delivery system
PH12013501994A1 (en) Controlled release pharmaceutical dosage forms
MY163809A (en) Transdermal drug delivery system containing donepezil
MD20160079A2 (ro) Sistem de livrare a medicamentului
WO2014116650A3 (en) Transdermal drug delivery system and method
EP3072506A4 (en) Carrier for drug delivery and conjugate, composition containing same, and method for administering same
PH12013502325A1 (en) Drug delivery system
HK1220109A1 (zh) 含卡巴拉汀的经皮给药系统
EP3664885A4 (en) TRANSDERMAL DRUG DELIVERY SYSTEM
EP3380176A4 (en) DEVICE, METHOD AND SYSTEM FOR DELIVERED QUANTUM MEDICINE DELIVERY ("TQD3")
MX2016008138A (es) Sistema para el suministro transdermico de ingredientes activos.
EP2691127A4 (en) IMPLANTABLE MINIATURE DRUG DELIVERY DEVICES AND INTRODUCTION SYSTEM FOR THE INTRODUCTION OF SUCH DEVICES
UA114101C2 (xx) Трансдермальна терапевтична система для введення фентанілу або його аналога
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
PH12016502537A1 (en) Composite preparation comprising active ingredient-containing film coating layer
MX2014005270A (es) Sistema de administracion vaginal con activiad osmotica.
MY166972A (en) Transdermal delivery system containing galantamine or salts thereof
HK1213822A1 (zh) 包含大环三烯活性剂和抗氧剂的可植入医疗装置的制造方法
PH12014502325A1 (en) Sustained release tablet containing levodropropizine and method for preparing same
WO2015026552A3 (en) Mucoadhesive devices for delivery of active agents
TH153173A (th) ระบบการนำส่งยา
HK40061220A (en) Thermally regulated transdermal drug delivery system
EP3843712A4 (en) METHOD FOR MANUFACTURING ACTIVE DRUG SUBSTANCE OF PIBRENTASVIR
EP3648746A4 (en) POROUS CERAMIC MATERIAL FOR DRUG DELIVERY AND RELEASE APPLICATIONS, AND DRUG DELIVERY AND RELEASE SYSTEM INCLUDING SUCH POROUS CERAMIC MATERIAL
AU2017904916A0 (en) Liposomal system for drug delivery